The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Board of Directors
    • Staff & Volunteers
    • The Antibody Society’s Standing Committees
      • Communication & Membership Committee
      • Finance & Audit Committee
      • Initiatives Committee
      • Meetings Committee
    • Advisors
    • Sponsors
    • James S. Huston Antibody Science Talent Award
      • JSH Award Criteria
  • Society meetings
    • Antibody Engineering & Therapeutics (US) 2020
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • Meeting reports
      • Keynote presentations
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2020
      • Antibody Engineering & Therapeutics Europe 2019
    • AIRR Community Meetings
    • FOCIS Symposia
    • Society-Funded Meetings
  • AIRR Community
    • AIRR News
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Data Representation Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Minimal Standards Working Group
      • Software Working Group
    • AIRR Community Sub-committees
      • Communications Sub-committee
      • Executive Sub-committee
      • Inferred Allele Review Committee
      • Meetings Sub-committee
    • AIRR Community Calendar
    • AIRR Community Resources
  • Members only
    • Login
    • Note to members
    • Antibodies in early-stage studies
    • Antibodies in late-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News You Should Know
    • Antibody therapeutics approved or in regulatory review in the EU or US
    • Research Resources
    • Education Resources
  • Career Center
  • Learning Center
    • Upcoming Webinars
    • Antibody Discovery & Development
    • Antibodies to Watch
    • Antibody Validation
  • COVID-19
    • Guide to “Coronavirus in the Crosshairs”
    • COVID-19 Biologics Tracker
    • Meeting Report: The Diagnostic Landscape for COVID-19
You are here: Home / 2019 Antibody Engineering & Therapeutics

2019 Antibody Engineering & Therapeutics

The Antibody Society held its 2019 annual meeting during December 9th-13th, in San Diego. The meeting was a great opportunity for Society members to connect with their fellow industry and academic scientists and executives from around the world, and learn about advances in antibody discovery and development.  As always, The Antibody Society’s members designed the scientific program and acted as session Chairs. This was our largest annual meeting yet, with over 1,000 attendees.

Sessions

The following pre-meeting workshops were held on December 9th: Introduction to Antibody Engineering (moderated by David Bramhill, PhD, Bramhill Biological Consulting, LLC); Bispecific Antibodies: New Strategies and Case Studies (moderated by Aran Labrijn, PhD, Genmab); and Machine Learning in Antibody and Protein Engineering (moderated by Sai Reddy, PhD, ETH Zurich and  Andrew Bradbury, MD, PhD, Specifica).

On December 10th, The Antibody Society’s 2019 President Kerry Chester, PhD (UCL Cancer Institute) and Vice President Paul Carter, PhD (Genentech, Inc.) opened the meeting with some inspiring remarks.

Keynotes were delivered by Janine Schuurman, PhD (Genmab), George Georgiou, PhD (The University of Texas at Austin), Gary Nabel, MD, PhD (Sanofi Global R&D), and Marjolein van Egmond, PhD (Amsterdam University Medical Center).

As always, one of the highlights of the conference was the “Antibodies to Watch in 2020” presentation by Janice Reichert, PhD (Executive Director of The Antibody Society, Editor-in-Chief of mAbs).  To update you on 2019 year-end results as well as early 2020 results, we are planning a webinar on ‘Antibodies to Watch in 2020’, which will be available from our Learning Center in early 2020.

Antibody Engineering & Therapeutics Student/Postdoc Poster Competition

To recognize the research activities of promising student/postdoc attendees of the Antibody Engineering & Therapeutics conference, The Antibody Society sponsored a poster competition for students and postdocs. The winners received complimentary registration, support for travel expenses, and an opportunity to present at the conference.
Congratulations to our winners:

Timothy Czajka, University of New York at Albany.
Poster title: RIP-Off: An Intrabody-based Strategy to Neutralize Ricin and other Ribosome-Inactivating Protein (RIP) Toxins.

Kamal Joshi, Genentech.
Poster title: Toward Deeper Understanding of Bispecific Antibodies


The winners’ award ceremony comments:

Timothy Czajka:
“Thank you again to the Antibody Society for this recognition and opportunity to speak here.  This is my third time attending the Antibody Engineering and Therapeutics conference and each time I’ve learned more than I could possibly remember and return to the lab with a huge surge of excitement and several new ideas that I’d like to apply to my own project.  I’m honored to be able to present my own research this year alongside so many fascinating talks and to be able to engage with many different experts in the field.  I would also like to thank my adviser, Nicholas Mantis, and Anne Messer for their help with my research and encouragement to attend and apply for this award.”

Kamal Joshi:
“It is an honor to receive this award. I would like to thank the judges for conferring this recognition on my work. I would also like to thank the Antibody Society, of course for funding my trip here but more importantly for organizing these fantastic meetings and providing a solid platform for the exchange of the latest information on antibody research and development benefiting all including early stage career scientists like me. It’s a real treat coming back to this meeting every time. Not only do I learn what is ongoing in the field, this meeting also provides me the opportunity to network with fellow scientists and facilitate connections. So again, thank you to the Antibody Society for this award. Thank you all.”

Meeting our members & Networking

The Society’s booth in the exhibit hall was the perfect spot for Society board members and volunteers to meet our members and discuss Society initiatives. The T shirts were very popular again this year – come to the booth early next time if you missed your chance to get one.
There were also lots of chances to have discussions with our corporate sponsors and fun at their booths!

 

 

At the Twist Bioscience booth
At the OmniAb booth
At the Ablexis / AlivaMab booth

At ImmunoPrecise’s booth
At Trianni’s booth
At Aldevron’s booth

KNect365 brings it all together!

We thank the fabulous folks at KNect365, Frances Pratt, Michael Keenan (and colleagues not seen here), for their fantastic management of the AE&T meeting!

Our fabulous conference managers

We look forward to seeing you in sunny San Diego at the 2020 AE&T meeting!

The meeting will be held December 13-17, 2020 at the Marriott Marquis San Diego.
All Society members receive discounts on registration to Antibody Engineering & Therapeutics
. Contact us at membership@antibodysociety.org for the code!

Career Center

Our Career Center is a premier resource to connect highly qualified talent with matching career opportunities. Visit for details on over 800 jobs!

AIRR Community

AIRR Community

The Adaptive Immune Receptor Repertoire Community is a research-driven group organizing around the use of high-throughput sequencing technologies to study antibody/B-cell and T-cell receptor repertoires.

Recent Posts

  • Call for Papers on Biopharmaceutical Informatics January 19, 2021
  • Antibodies to Watch in 2021 is now online! January 19, 2021
  • Successful AIRR Community Meeting V January 15, 2021

Archives

Follow us online

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • Privacy & Terms of Use
  • About
  • Board of Directors
  • Advisors
  • Sponsors
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals